| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, X-Ray Computed | 62 | 2025 | 2666 | 2.160 |
Why?
|
| Diagnostic Imaging | 13 | 2016 | 467 | 2.150 |
Why?
|
| Multidetector Computed Tomography | 6 | 2025 | 57 | 1.620 |
Why?
|
| Incidental Findings | 8 | 2017 | 100 | 1.210 |
Why?
|
| Liver Neoplasms | 10 | 2021 | 831 | 1.150 |
Why?
|
| Esophageal Neoplasms | 9 | 2015 | 353 | 1.050 |
Why?
|
| Radiography | 20 | 2021 | 764 | 0.910 |
Why?
|
| Intestinal Perforation | 3 | 2025 | 38 | 0.900 |
Why?
|
| Abdomen, Acute | 4 | 2015 | 21 | 0.900 |
Why?
|
| Diagnosis, Differential | 30 | 2025 | 1567 | 0.870 |
Why?
|
| Barium Sulfate | 5 | 2021 | 37 | 0.800 |
Why?
|
| Stomach Neoplasms | 8 | 2013 | 319 | 0.800 |
Why?
|
| Contrast Media | 8 | 2025 | 1011 | 0.750 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2021 | 15 | 0.680 |
Why?
|
| Liver Cirrhosis | 3 | 2021 | 288 | 0.680 |
Why?
|
| Magnetic Resonance Imaging | 15 | 2021 | 3606 | 0.650 |
Why?
|
| Carcinoma, Hepatocellular | 5 | 2021 | 450 | 0.640 |
Why?
|
| Gallbladder Diseases | 3 | 2010 | 21 | 0.600 |
Why?
|
| Ultrasonography | 21 | 2015 | 720 | 0.600 |
Why?
|
| Splenic Diseases | 2 | 2015 | 12 | 0.600 |
Why?
|
| Radiography, Abdominal | 8 | 2017 | 63 | 0.590 |
Why?
|
| Ischemia | 4 | 2008 | 262 | 0.560 |
Why?
|
| Gastrointestinal Diseases | 4 | 2015 | 155 | 0.530 |
Why?
|
| Lymphoma | 4 | 2016 | 254 | 0.510 |
Why?
|
| Peritoneal Neoplasms | 2 | 2016 | 195 | 0.510 |
Why?
|
| Humans | 120 | 2025 | 98080 | 0.510 |
Why?
|
| Panniculitis, Peritoneal | 1 | 2016 | 4 | 0.510 |
Why?
|
| Intestinal Obstruction | 3 | 2015 | 97 | 0.500 |
Why?
|
| Duodenal Diseases | 5 | 2025 | 26 | 0.460 |
Why?
|
| Intestine, Small | 6 | 2008 | 318 | 0.460 |
Why?
|
| Pancreatic Cyst | 3 | 2012 | 29 | 0.450 |
Why?
|
| Abdominal Neoplasms | 5 | 2009 | 38 | 0.450 |
Why?
|
| Biliary Tract Neoplasms | 4 | 2012 | 38 | 0.440 |
Why?
|
| Abdominal Pain | 1 | 2015 | 148 | 0.420 |
Why?
|
| Pancreatic Diseases | 6 | 2006 | 61 | 0.410 |
Why?
|
| Liver Diseases | 3 | 2011 | 249 | 0.410 |
Why?
|
| Colon | 10 | 2008 | 562 | 0.380 |
Why?
|
| Colitis | 8 | 2001 | 264 | 0.380 |
Why?
|
| Adnexal Diseases | 2 | 2011 | 23 | 0.380 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2016 | 384 | 0.380 |
Why?
|
| Crohn Disease | 12 | 2001 | 844 | 0.380 |
Why?
|
| Ampulla of Vater | 3 | 2025 | 25 | 0.370 |
Why?
|
| Kidney Neoplasms | 5 | 2016 | 556 | 0.370 |
Why?
|
| Pelvic Neoplasms | 2 | 2010 | 43 | 0.370 |
Why?
|
| Neoplasm Staging | 12 | 2017 | 2080 | 0.360 |
Why?
|
| Common Bile Duct Neoplasms | 2 | 2025 | 8 | 0.350 |
Why?
|
| Intestinal Neoplasms | 2 | 2006 | 77 | 0.350 |
Why?
|
| Positron-Emission Tomography | 5 | 2016 | 354 | 0.340 |
Why?
|
| Adnexa Uteri | 1 | 2011 | 11 | 0.340 |
Why?
|
| Barrett Esophagus | 1 | 2011 | 94 | 0.330 |
Why?
|
| Adenocarcinoma | 6 | 2006 | 1211 | 0.330 |
Why?
|
| Intestines | 3 | 2015 | 441 | 0.320 |
Why?
|
| Intestinal Diseases | 3 | 2008 | 84 | 0.320 |
Why?
|
| Abdomen | 2 | 2016 | 120 | 0.320 |
Why?
|
| Infarction | 4 | 2008 | 25 | 0.310 |
Why?
|
| Genital Neoplasms, Female | 2 | 2011 | 118 | 0.310 |
Why?
|
| Colitis, Ulcerative | 8 | 2001 | 824 | 0.310 |
Why?
|
| Abdominal Cavity | 1 | 2009 | 17 | 0.310 |
Why?
|
| Carcinoid Tumor | 3 | 2006 | 46 | 0.290 |
Why?
|
| Neoplasm Metastasis | 4 | 2012 | 1089 | 0.270 |
Why?
|
| Prostatic Neoplasms | 4 | 2016 | 1836 | 0.270 |
Why?
|
| Male | 56 | 2025 | 47076 | 0.270 |
Why?
|
| Middle Aged | 47 | 2025 | 29428 | 0.260 |
Why?
|
| Female | 51 | 2025 | 51536 | 0.260 |
Why?
|
| Aged | 34 | 2025 | 21758 | 0.260 |
Why?
|
| Reproducibility of Results | 7 | 2025 | 2784 | 0.240 |
Why?
|
| Adult | 37 | 2025 | 29539 | 0.240 |
Why?
|
| Mesentery | 5 | 2016 | 49 | 0.230 |
Why?
|
| Gastrointestinal Neoplasms | 3 | 2005 | 112 | 0.230 |
Why?
|
| Aged, 80 and over | 11 | 2025 | 7389 | 0.230 |
Why?
|
| Duodenal Neoplasms | 1 | 2025 | 21 | 0.220 |
Why?
|
| Sensitivity and Specificity | 7 | 2025 | 1945 | 0.220 |
Why?
|
| Liver | 8 | 2006 | 1231 | 0.220 |
Why?
|
| Endosonography | 4 | 2010 | 103 | 0.220 |
Why?
|
| Colorectal Neoplasms | 3 | 2005 | 1103 | 0.210 |
Why?
|
| Obesity | 1 | 2011 | 1061 | 0.210 |
Why?
|
| Cysts | 3 | 2002 | 100 | 0.210 |
Why?
|
| Carcinoma | 3 | 2012 | 440 | 0.200 |
Why?
|
| Enema | 2 | 2021 | 37 | 0.200 |
Why?
|
| Biliary Tract Diseases | 4 | 1998 | 36 | 0.200 |
Why?
|
| Esophagitis | 3 | 1996 | 40 | 0.190 |
Why?
|
| Retrospective Studies | 10 | 2025 | 10973 | 0.180 |
Why?
|
| Nutrition Assessment | 1 | 2001 | 23 | 0.170 |
Why?
|
| Retroperitoneal Space | 3 | 2000 | 43 | 0.170 |
Why?
|
| Food | 1 | 2001 | 93 | 0.170 |
Why?
|
| Body Fluids | 1 | 2000 | 35 | 0.160 |
Why?
|
| Fascia | 1 | 2000 | 32 | 0.160 |
Why?
|
| Prognosis | 6 | 2021 | 4116 | 0.150 |
Why?
|
| Gallstones | 3 | 1988 | 21 | 0.150 |
Why?
|
| Stomach Volvulus | 1 | 1998 | 3 | 0.140 |
Why?
|
| Water Microbiology | 2 | 2009 | 13 | 0.140 |
Why?
|
| Stomach Diseases | 1 | 1999 | 18 | 0.140 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2021 | 304 | 0.140 |
Why?
|
| Diet | 1 | 2001 | 469 | 0.140 |
Why?
|
| AIDS-Associated Nephropathy | 1 | 1998 | 2 | 0.140 |
Why?
|
| Algorithms | 3 | 2017 | 2002 | 0.140 |
Why?
|
| Gastrostomy | 1 | 1998 | 67 | 0.140 |
Why?
|
| Spleen | 4 | 2015 | 375 | 0.140 |
Why?
|
| Iopamidol | 2 | 2013 | 9 | 0.140 |
Why?
|
| Acute Disease | 3 | 2015 | 860 | 0.130 |
Why?
|
| Models, Statistical | 1 | 2001 | 601 | 0.130 |
Why?
|
| Radiographic Image Enhancement | 3 | 2015 | 449 | 0.130 |
Why?
|
| Postoperative Complications | 3 | 2004 | 2681 | 0.130 |
Why?
|
| Pancreas | 4 | 2006 | 269 | 0.120 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 4 | 2010 | 72 | 0.120 |
Why?
|
| Infant | 4 | 2021 | 3328 | 0.120 |
Why?
|
| Data Collection | 1 | 2017 | 376 | 0.120 |
Why?
|
| Polyps | 1 | 1996 | 26 | 0.120 |
Why?
|
| Observer Variation | 3 | 2017 | 579 | 0.120 |
Why?
|
| Risk Management | 1 | 2016 | 45 | 0.120 |
Why?
|
| Guideline Adherence | 1 | 2017 | 250 | 0.110 |
Why?
|
| Intestinal Diseases, Parasitic | 1 | 1995 | 5 | 0.110 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 1995 | 677 | 0.110 |
Why?
|
| Multimodal Imaging | 2 | 2015 | 116 | 0.110 |
Why?
|
| Pancreatitis | 6 | 1987 | 105 | 0.110 |
Why?
|
| Enterocolitis | 1 | 1995 | 13 | 0.110 |
Why?
|
| United States | 3 | 2017 | 8197 | 0.110 |
Why?
|
| Endoscopy | 1 | 1998 | 384 | 0.110 |
Why?
|
| Virus Diseases | 1 | 1995 | 83 | 0.110 |
Why?
|
| Intestinal Mucosa | 2 | 1999 | 834 | 0.100 |
Why?
|
| Hemangioma | 2 | 2012 | 62 | 0.100 |
Why?
|
| Liver Circulation | 1 | 1994 | 28 | 0.100 |
Why?
|
| Adenocarcinoma, Mucinous | 2 | 2012 | 53 | 0.100 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 4025 | 0.100 |
Why?
|
| Bacterial Infections | 1 | 1995 | 184 | 0.100 |
Why?
|
| Clinical Decision-Making | 1 | 2016 | 305 | 0.100 |
Why?
|
| Gastrointestinal Tract | 1 | 2015 | 198 | 0.100 |
Why?
|
| Societies, Medical | 1 | 2017 | 682 | 0.100 |
Why?
|
| Biopsy | 2 | 2016 | 1224 | 0.100 |
Why?
|
| Radiology | 1 | 2016 | 215 | 0.100 |
Why?
|
| Focal Nodular Hyperplasia | 1 | 2012 | 10 | 0.090 |
Why?
|
| Cystadenoma, Serous | 1 | 2012 | 16 | 0.090 |
Why?
|
| Breast Neoplasms | 2 | 2010 | 3272 | 0.090 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1284 | 0.090 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2013 | 462 | 0.090 |
Why?
|
| Electronic Health Records | 1 | 2016 | 442 | 0.090 |
Why?
|
| Radionuclide Imaging | 4 | 2005 | 183 | 0.090 |
Why?
|
| Lymphatic Metastasis | 4 | 2009 | 520 | 0.090 |
Why?
|
| Databases, Factual | 1 | 2016 | 1094 | 0.090 |
Why?
|
| Adenoma | 2 | 2012 | 260 | 0.090 |
Why?
|
| Pattern Recognition, Automated | 1 | 2013 | 218 | 0.090 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2017 | 659 | 0.090 |
Why?
|
| Mesenteric Vascular Occlusion | 2 | 2008 | 20 | 0.090 |
Why?
|
| Adipokines | 1 | 2011 | 20 | 0.090 |
Why?
|
| Gallbladder | 3 | 2012 | 33 | 0.090 |
Why?
|
| Diverticulitis | 1 | 1991 | 9 | 0.090 |
Why?
|
| Histological Techniques | 1 | 2011 | 33 | 0.090 |
Why?
|
| Early Detection of Cancer | 1 | 2016 | 550 | 0.090 |
Why?
|
| Hemosiderosis | 1 | 1991 | 3 | 0.080 |
Why?
|
| Preoperative Period | 1 | 2011 | 102 | 0.080 |
Why?
|
| Body Composition | 1 | 2011 | 88 | 0.080 |
Why?
|
| Budd-Chiari Syndrome | 2 | 1988 | 8 | 0.080 |
Why?
|
| Lymphatic Diseases | 2 | 1988 | 31 | 0.080 |
Why?
|
| Blood Vessels | 1 | 2010 | 92 | 0.080 |
Why?
|
| Cholecystography | 2 | 1989 | 6 | 0.080 |
Why?
|
| Postoperative Period | 1 | 2011 | 321 | 0.080 |
Why?
|
| Metabolic Syndrome | 1 | 2011 | 125 | 0.080 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1997 | 1105 | 0.080 |
Why?
|
| Digestive System Neoplasms | 1 | 2009 | 20 | 0.080 |
Why?
|
| Ligaments | 1 | 2009 | 33 | 0.080 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2009 | 42 | 0.080 |
Why?
|
| Omentum | 1 | 2009 | 69 | 0.070 |
Why?
|
| Colonic Diseases | 3 | 2001 | 59 | 0.070 |
Why?
|
| Digestive System | 3 | 2004 | 42 | 0.070 |
Why?
|
| Endoscopy, Digestive System | 3 | 2012 | 73 | 0.070 |
Why?
|
| Sewage | 1 | 2009 | 4 | 0.070 |
Why?
|
| Weather | 1 | 2009 | 8 | 0.070 |
Why?
|
| Fresh Water | 1 | 2009 | 21 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 630 | 0.070 |
Why?
|
| Enterobacteriaceae | 1 | 2009 | 22 | 0.070 |
Why?
|
| Spinal Cord Injuries | 2 | 1999 | 120 | 0.070 |
Why?
|
| Hepatitis, Chronic | 1 | 1988 | 5 | 0.070 |
Why?
|
| HIV Infections | 1 | 1998 | 1018 | 0.070 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2009 | 90 | 0.070 |
Why?
|
| Young Adult | 1 | 2021 | 7507 | 0.070 |
Why?
|
| Body Mass Index | 1 | 2011 | 850 | 0.070 |
Why?
|
| Cholecystitis | 2 | 2002 | 17 | 0.060 |
Why?
|
| Adipose Tissue | 3 | 1995 | 280 | 0.060 |
Why?
|
| Brachytherapy | 2 | 2012 | 139 | 0.060 |
Why?
|
| Enteritis | 1 | 1987 | 23 | 0.060 |
Why?
|
| Vena Cava, Inferior | 4 | 1994 | 140 | 0.060 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2006 | 23 | 0.060 |
Why?
|
| Lymph Nodes | 1 | 2010 | 560 | 0.060 |
Why?
|
| Feces | 1 | 2009 | 387 | 0.060 |
Why?
|
| Cholangiography | 2 | 2002 | 38 | 0.060 |
Why?
|
| Duodenitis | 1 | 1986 | 3 | 0.060 |
Why?
|
| AIDS-Related Opportunistic Infections | 2 | 2004 | 24 | 0.060 |
Why?
|
| Uterine Neoplasms | 1 | 2010 | 289 | 0.060 |
Why?
|
| Pharyngitis | 1 | 1986 | 17 | 0.060 |
Why?
|
| Ascites | 2 | 1985 | 55 | 0.060 |
Why?
|
| Ovarian Neoplasms | 2 | 2010 | 825 | 0.060 |
Why?
|
| Gastritis | 1 | 1986 | 38 | 0.060 |
Why?
|
| Graft vs Host Disease | 2 | 2001 | 379 | 0.060 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 2037 | 0.060 |
Why?
|
| Portal Vein | 3 | 1994 | 121 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 2 | 1997 | 582 | 0.060 |
Why?
|
| Hypertension, Portal | 1 | 1985 | 46 | 0.050 |
Why?
|
| Iron | 2 | 1999 | 178 | 0.050 |
Why?
|
| Industrial Oils | 1 | 2004 | 1 | 0.050 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 1996 | 68 | 0.050 |
Why?
|
| Digestive System Diseases | 1 | 2004 | 19 | 0.050 |
Why?
|
| Pancreatic Pseudocyst | 2 | 2002 | 9 | 0.050 |
Why?
|
| Kidney Transplantation | 1 | 1991 | 939 | 0.050 |
Why?
|
| Laryngeal Neoplasms | 1 | 2004 | 89 | 0.050 |
Why?
|
| Occupational Diseases | 1 | 2004 | 58 | 0.050 |
Why?
|
| Arthroplasty | 1 | 1983 | 40 | 0.050 |
Why?
|
| Hip Joint | 1 | 1983 | 60 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 4 | 2002 | 769 | 0.050 |
Why?
|
| Immunocompromised Host | 1 | 2004 | 139 | 0.050 |
Why?
|
| Image Enhancement | 1 | 2006 | 503 | 0.050 |
Why?
|
| Cholelithiasis | 1 | 2002 | 36 | 0.050 |
Why?
|
| Urography | 1 | 1982 | 30 | 0.050 |
Why?
|
| Gallbladder Neoplasms | 1 | 2002 | 24 | 0.050 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 1982 | 7 | 0.050 |
Why?
|
| Occupational Exposure | 1 | 2004 | 99 | 0.050 |
Why?
|
| Risk Factors | 4 | 1997 | 6233 | 0.050 |
Why?
|
| Iodine Radioisotopes | 1 | 1983 | 145 | 0.050 |
Why?
|
| Prenatal Diagnosis | 1 | 1982 | 107 | 0.040 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2001 | 244 | 0.040 |
Why?
|
| Preoperative Care | 2 | 2017 | 418 | 0.040 |
Why?
|
| Diet Records | 1 | 2001 | 20 | 0.040 |
Why?
|
| Urethra | 1 | 1982 | 108 | 0.040 |
Why?
|
| Adrenal Gland Neoplasms | 4 | 2010 | 84 | 0.040 |
Why?
|
| Energy Intake | 1 | 2001 | 99 | 0.040 |
Why?
|
| Bias | 1 | 2001 | 139 | 0.040 |
Why?
|
| Hepatic Veins | 2 | 1994 | 27 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 2012 | 1751 | 0.040 |
Why?
|
| Abscess | 4 | 1985 | 94 | 0.040 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1983 | 244 | 0.040 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2001 | 52 | 0.040 |
Why?
|
| Sphenoid Sinus | 1 | 1980 | 8 | 0.040 |
Why?
|
| Mucocele | 1 | 1980 | 5 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2006 | 1302 | 0.040 |
Why?
|
| Ulna | 1 | 1980 | 15 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2001 | 578 | 0.040 |
Why?
|
| Skull Neoplasms | 1 | 1980 | 25 | 0.040 |
Why?
|
| Humerus | 1 | 1980 | 35 | 0.040 |
Why?
|
| Sella Turcica | 1 | 1980 | 18 | 0.040 |
Why?
|
| Cholangiocarcinoma | 1 | 2001 | 83 | 0.040 |
Why?
|
| Leukemia | 1 | 1982 | 308 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2001 | 726 | 0.040 |
Why?
|
| Gastric Mucosa | 2 | 1999 | 72 | 0.040 |
Why?
|
| Thrombosis | 3 | 1988 | 318 | 0.040 |
Why?
|
| Bezoars | 1 | 1999 | 3 | 0.040 |
Why?
|
| Erythromycin | 1 | 1999 | 9 | 0.040 |
Why?
|
| Adrenergic Agents | 1 | 1999 | 6 | 0.040 |
Why?
|
| Chicago | 3 | 2009 | 1513 | 0.040 |
Why?
|
| Potassium Chloride | 1 | 1999 | 75 | 0.040 |
Why?
|
| Cholinergic Antagonists | 1 | 1999 | 30 | 0.040 |
Why?
|
| Gastrointestinal Motility | 1 | 1999 | 26 | 0.040 |
Why?
|
| Dopamine Agents | 1 | 1999 | 33 | 0.040 |
Why?
|
| Diaphragm | 1 | 1999 | 76 | 0.040 |
Why?
|
| Athletic Injuries | 1 | 1980 | 113 | 0.040 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2000 | 125 | 0.040 |
Why?
|
| Narcotics | 1 | 1999 | 74 | 0.030 |
Why?
|
| Environmental Monitoring | 2 | 2009 | 93 | 0.030 |
Why?
|
| Sarcoma, Kaposi | 1 | 1998 | 17 | 0.030 |
Why?
|
| Splenic Vein | 2 | 1988 | 5 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1999 | 305 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2001 | 1782 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1999 | 255 | 0.030 |
Why?
|
| Lymph Node Excision | 2 | 2012 | 238 | 0.030 |
Why?
|
| Adolescent | 8 | 1994 | 10080 | 0.030 |
Why?
|
| Drainage | 2 | 2012 | 176 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2016 | 2585 | 0.030 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 1997 | 163 | 0.030 |
Why?
|
| Urologic Diseases | 1 | 1996 | 38 | 0.030 |
Why?
|
| Truth Disclosure | 1 | 2016 | 75 | 0.030 |
Why?
|
| Muscle, Smooth | 2 | 1995 | 299 | 0.030 |
Why?
|
| Child | 7 | 1992 | 7681 | 0.030 |
Why?
|
| Esophagectomy | 1 | 2015 | 93 | 0.030 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2015 | 146 | 0.030 |
Why?
|
| Colitis, Ischemic | 1 | 1994 | 4 | 0.030 |
Why?
|
| Glycolysis | 1 | 2015 | 198 | 0.030 |
Why?
|
| Intestinal Fistula | 3 | 1984 | 32 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2015 | 333 | 0.030 |
Why?
|
| Cholecystokinin | 1 | 1993 | 15 | 0.030 |
Why?
|
| Liver Cirrhosis, Alcoholic | 2 | 1985 | 23 | 0.030 |
Why?
|
| Triiodobenzoic Acids | 1 | 2013 | 7 | 0.020 |
Why?
|
| Tuberculosis, Gastrointestinal | 2 | 2004 | 5 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2000 | 1535 | 0.020 |
Why?
|
| Multiple Sclerosis | 1 | 1996 | 268 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2015 | 525 | 0.020 |
Why?
|
| Radiation Injuries | 1 | 1994 | 160 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 922 | 0.020 |
Why?
|
| Hydronephrosis | 2 | 1982 | 23 | 0.020 |
Why?
|
| Jaundice, Obstructive | 1 | 2012 | 11 | 0.020 |
Why?
|
| Bile Ducts, Extrahepatic | 1 | 2012 | 12 | 0.020 |
Why?
|
| Peptic Ulcer | 2 | 1982 | 18 | 0.020 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2012 | 68 | 0.020 |
Why?
|
| Electroporation | 1 | 2012 | 61 | 0.020 |
Why?
|
| Spectrum Analysis | 1 | 2012 | 119 | 0.020 |
Why?
|
| Colonic Neoplasms | 3 | 1992 | 582 | 0.020 |
Why?
|
| Radiology, Interventional | 1 | 2012 | 62 | 0.020 |
Why?
|
| Rectum | 2 | 2000 | 150 | 0.020 |
Why?
|
| Ablation Techniques | 1 | 2012 | 52 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 1 | 2012 | 126 | 0.020 |
Why?
|
| Stomach Ulcer | 2 | 1982 | 23 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2015 | 478 | 0.020 |
Why?
|
| Photochemotherapy | 1 | 2012 | 101 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2006 | 3212 | 0.020 |
Why?
|
| Biliary Tract | 2 | 2004 | 11 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2012 | 217 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 2012 | 352 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 1993 | 314 | 0.020 |
Why?
|
| Mesenteric Veins | 2 | 1988 | 38 | 0.020 |
Why?
|
| Watchful Waiting | 1 | 2011 | 73 | 0.020 |
Why?
|
| Laparoscopy | 1 | 1997 | 791 | 0.020 |
Why?
|
| Uncertainty | 1 | 2010 | 81 | 0.020 |
Why?
|
| Radiotherapy | 1 | 2012 | 325 | 0.020 |
Why?
|
| Calcinosis | 3 | 1992 | 220 | 0.020 |
Why?
|
| Water Movements | 1 | 2009 | 9 | 0.020 |
Why?
|
| Rain | 1 | 2009 | 9 | 0.020 |
Why?
|
| Water Pollution | 1 | 2009 | 9 | 0.020 |
Why?
|
| Consensus | 1 | 2010 | 315 | 0.020 |
Why?
|
| Hernia | 2 | 1992 | 21 | 0.020 |
Why?
|
| Stents | 1 | 2012 | 433 | 0.020 |
Why?
|
| Embolization, Therapeutic | 1 | 2012 | 320 | 0.020 |
Why?
|
| Genital Diseases, Male | 1 | 1988 | 8 | 0.020 |
Why?
|
| Chronic Disease | 1 | 1992 | 985 | 0.020 |
Why?
|
| von Hippel-Lindau Disease | 1 | 1988 | 16 | 0.020 |
Why?
|
| Seminal Vesicles | 1 | 1988 | 40 | 0.020 |
Why?
|
| Digestive System Surgical Procedures | 1 | 1989 | 146 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 1999 | 2373 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2006 | 1995 | 0.020 |
Why?
|
| Aortic Aneurysm | 2 | 1984 | 72 | 0.020 |
Why?
|
| Choristoma | 1 | 1987 | 59 | 0.020 |
Why?
|
| Ossification, Heterotopic | 1 | 1987 | 34 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2012 | 604 | 0.020 |
Why?
|
| Mammography | 1 | 2010 | 504 | 0.020 |
Why?
|
| Laparotomy | 1 | 2006 | 64 | 0.020 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1988 | 262 | 0.010 |
Why?
|
| Cholangitis | 1 | 1986 | 19 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 1565 | 0.010 |
Why?
|
| Radiology Information Systems | 1 | 2006 | 81 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1987 | 271 | 0.010 |
Why?
|
| Hepatitis | 1 | 1986 | 32 | 0.010 |
Why?
|
| Bone and Bones | 1 | 1987 | 270 | 0.010 |
Why?
|
| Peritoneal Diseases | 1 | 1985 | 15 | 0.010 |
Why?
|
| Cellulitis | 1 | 1985 | 17 | 0.010 |
Why?
|
| Duodenum | 1 | 1986 | 112 | 0.010 |
Why?
|
| Hemochromatosis | 1 | 1985 | 12 | 0.010 |
Why?
|
| Aneurysm, Infected | 1 | 1984 | 14 | 0.010 |
Why?
|
| Brain Edema | 1 | 1985 | 55 | 0.010 |
Why?
|
| Liver Transplantation | 1 | 2012 | 1235 | 0.010 |
Why?
|
| Metallurgy | 1 | 2004 | 2 | 0.010 |
Why?
|
| Automobiles | 1 | 2004 | 14 | 0.010 |
Why?
|
| Tuberculosis, Hepatic | 1 | 2004 | 1 | 0.010 |
Why?
|
| Cryptosporidiosis | 1 | 2004 | 7 | 0.010 |
Why?
|
| Bacteria | 1 | 2009 | 545 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2006 | 801 | 0.010 |
Why?
|
| Intestinal Polyps | 1 | 1983 | 27 | 0.010 |
Why?
|
| Pneumatosis Cystoides Intestinalis | 1 | 1983 | 3 | 0.010 |
Why?
|
| Fatty Liver | 1 | 1985 | 119 | 0.010 |
Why?
|
| Acetabulum | 1 | 1983 | 22 | 0.010 |
Why?
|
| Hip Prosthesis | 1 | 1983 | 28 | 0.010 |
Why?
|
| Adenoma, Bile Duct | 1 | 1983 | 4 | 0.010 |
Why?
|
| Herpes Simplex | 1 | 2004 | 79 | 0.010 |
Why?
|
| Diatrizoate Meglumine | 1 | 1983 | 10 | 0.010 |
Why?
|
| Cytomegalovirus Infections | 1 | 2004 | 116 | 0.010 |
Why?
|
| Diverticulitis, Colonic | 1 | 1982 | 11 | 0.010 |
Why?
|
| Genital Neoplasms, Male | 1 | 1982 | 9 | 0.010 |
Why?
|
| Jaundice | 1 | 1982 | 14 | 0.010 |
Why?
|
| Hemangioma, Cavernous | 1 | 1983 | 66 | 0.010 |
Why?
|
| Pregnancy Trimester, Second | 1 | 1982 | 70 | 0.010 |
Why?
|
| Fetal Diseases | 1 | 1982 | 71 | 0.010 |
Why?
|
| Celiac Disease | 1 | 1986 | 229 | 0.010 |
Why?
|
| Bronchopulmonary Sequestration | 1 | 1982 | 3 | 0.010 |
Why?
|
| Splenomegaly | 1 | 1982 | 19 | 0.010 |
Why?
|
| Research Design | 1 | 2006 | 660 | 0.010 |
Why?
|
| Hepatomegaly | 1 | 1982 | 11 | 0.010 |
Why?
|
| Leukemia, Lymphoid | 1 | 1982 | 48 | 0.010 |
Why?
|
| Peritoneal Dialysis | 1 | 1982 | 31 | 0.010 |
Why?
|
| Hematoma | 1 | 1982 | 106 | 0.010 |
Why?
|
| Superior Mesenteric Artery Syndrome | 1 | 1981 | 2 | 0.010 |
Why?
|
| Fecal Impaction | 1 | 1981 | 4 | 0.010 |
Why?
|
| Progeria | 1 | 1981 | 5 | 0.010 |
Why?
|
| Asbestos | 1 | 1981 | 25 | 0.010 |
Why?
|
| Pulmonary Atelectasis | 1 | 1981 | 19 | 0.010 |
Why?
|
| Pleural Diseases | 1 | 1981 | 15 | 0.010 |
Why?
|
| Artificial Intelligence | 1 | 2006 | 473 | 0.010 |
Why?
|
| Esophagus | 1 | 1981 | 108 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 1986 | 638 | 0.010 |
Why?
|
| Leukemia, Myeloid | 1 | 1982 | 241 | 0.010 |
Why?
|
| Radioimmunodetection | 1 | 2000 | 12 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 2000 | 103 | 0.010 |
Why?
|
| Tennis | 1 | 1980 | 3 | 0.010 |
Why?
|
| Ulna Fractures | 1 | 1980 | 7 | 0.010 |
Why?
|
| Child, Preschool | 2 | 1992 | 4001 | 0.010 |
Why?
|
| Gastric Fistula | 1 | 1980 | 4 | 0.010 |
Why?
|
| Pylorus | 1 | 1980 | 15 | 0.010 |
Why?
|
| Baseball | 1 | 1980 | 19 | 0.010 |
Why?
|
| Mutation | 1 | 2012 | 4392 | 0.010 |
Why?
|
| Elbow Joint | 1 | 1980 | 33 | 0.010 |
Why?
|
| Amyloidosis | 1 | 1981 | 136 | 0.010 |
Why?
|
| Humeral Fractures | 1 | 1980 | 31 | 0.010 |
Why?
|
| Cartilage, Articular | 1 | 1980 | 86 | 0.010 |
Why?
|
| Incidence | 1 | 2004 | 1779 | 0.010 |
Why?
|
| Tidal Volume | 1 | 1999 | 65 | 0.010 |
Why?
|
| Phrenic Nerve | 1 | 1999 | 49 | 0.010 |
Why?
|
| Equipment Contamination | 1 | 1999 | 28 | 0.010 |
Why?
|
| Atrophy | 1 | 1999 | 130 | 0.010 |
Why?
|
| Electric Stimulation Therapy | 1 | 1999 | 64 | 0.010 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1982 | 401 | 0.010 |
Why?
|
| Respiration | 1 | 1999 | 274 | 0.010 |
Why?
|
| Lymphoma, AIDS-Related | 1 | 1996 | 7 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1982 | 2529 | 0.010 |
Why?
|
| Respiration, Artificial | 1 | 1999 | 462 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1982 | 849 | 0.010 |
Why?
|
| Pregnancy | 1 | 1982 | 3244 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 1996 | 214 | 0.010 |
Why?
|
| Pelvis | 2 | 1987 | 106 | 0.010 |
Why?
|
| Age Factors | 1 | 1979 | 1962 | 0.010 |
Why?
|
| Pneumocystis Infections | 1 | 1993 | 3 | 0.010 |
Why?
|
| Aorta, Thoracic | 2 | 1984 | 154 | 0.010 |
Why?
|
| Recurrence | 1 | 1996 | 1254 | 0.010 |
Why?
|
| Substance Abuse, Intravenous | 1 | 1993 | 76 | 0.010 |
Why?
|
| Fat Necrosis | 1 | 1992 | 6 | 0.010 |
Why?
|
| Torsion Abnormality | 1 | 1992 | 13 | 0.010 |
Why?
|
| Ascitic Fluid | 1 | 1992 | 36 | 0.010 |
Why?
|
| Lipoma | 1 | 1992 | 23 | 0.010 |
Why?
|
| Prevalence | 1 | 1996 | 1384 | 0.010 |
Why?
|
| Heart Failure | 1 | 1982 | 1491 | 0.010 |
Why?
|
| Mass Screening | 1 | 1996 | 745 | 0.000 |
Why?
|
| Gases | 1 | 1988 | 31 | 0.000 |
Why?
|
| Hip | 1 | 1987 | 18 | 0.000 |
Why?
|
| Muscular Diseases | 1 | 1987 | 66 | 0.000 |
Why?
|
| Pressure Ulcer | 1 | 1987 | 45 | 0.000 |
Why?
|
| Infusions, Parenteral | 1 | 1985 | 47 | 0.000 |
Why?
|
| Intraoperative Period | 1 | 1985 | 91 | 0.000 |
Why?
|
| Pancreatic Ducts | 1 | 1985 | 37 | 0.000 |
Why?
|
| Prospective Studies | 2 | 1985 | 4823 | 0.000 |
Why?
|
| Aorta, Abdominal | 1 | 1984 | 57 | 0.000 |
Why?
|
| Osteomyelitis | 1 | 1984 | 58 | 0.000 |
Why?
|
| Spinal Diseases | 1 | 1984 | 96 | 0.000 |
Why?
|
| Common Bile Duct Diseases | 1 | 1983 | 9 | 0.000 |
Why?
|
| Bile Duct Diseases | 1 | 1983 | 23 | 0.000 |
Why?
|
| Dilatation, Pathologic | 1 | 1983 | 47 | 0.000 |
Why?
|
| Esophageal Fistula | 1 | 1982 | 13 | 0.000 |
Why?
|
| Esophageal Stenosis | 1 | 1982 | 25 | 0.000 |
Why?
|
| Deglutition Disorders | 1 | 1982 | 126 | 0.000 |
Why?
|
| Peptic Ulcer Perforation | 1 | 1980 | 4 | 0.000 |
Why?
|
| Anti-Ulcer Agents | 1 | 1980 | 22 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 1986 | 1327 | 0.000 |
Why?
|
| Brain Neoplasms | 1 | 1985 | 839 | 0.000 |
Why?
|